Changes in levels of peripheral hormones controlling appetite are inconsistent with hyperphagia in leptin-deficient subjects

Endocrine

Volumn 45, Issue 3, 2014, Pages 401-408

  Saeed, Sadia ^a   Bech, Paul R ^a   Hafeez, Tayyaba ^b   Alam, Rabail ^c   Falchi, Mario ^a   Ghatei, Mohammad A ^a   Bloom, Stephen R ^a   Arslan, Muhammad ^c,d   Froguel, Philippe ^a,e  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b SERVICES HOSPITAL   (Pakistan)

^c UNIVERSITY OF LAHORE   (Pakistan)

^d FORMAN CHRISTIAN COLLEGE A CHARTERED UNIVERSITY   (Pakistan)

^e UNIV LILLE   (France)

Author keywords

Ghrelin; GLP 1; Insulin; Leptin deficiency; PYY

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; PEPTIDE YY;

ADULT; APPETITE; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOOD INTAKE; GENE MUTATION; GHRELIN BLOOD LEVEL; GLUCAGON LIKE PEPTIDE 1 BLOOD LEVEL; HETEROZYGOSITY; HOMOZYGOSITY; HORMONE BLOOD LEVEL; HUMAN; HYPERPHAGIA; IMMUNOASSAY; INSULIN BLOOD LEVEL; LEP GENE; LEPTIN BLOOD LEVEL; LEPTIN DEFICIENCY; MALE; PEPTIDE YY BLOOD LEVEL; POSTPRANDIAL STATE; PRIORITY JOURNAL; WILD TYPE; ADOLESCENT; BLOOD; CHILD; CONSANGUINITY; DEFICIENCY; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MIDDLE AGED; MUTATION; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CONSANGUINITY; FASTING; FEMALE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERPHAGIA; INSULIN; LEPTIN; MALE; MIDDLE AGED; MUTATION; PEPTIDE YY; POSTPRANDIAL PERIOD; YOUNG ADULT;

EID: 84897043018     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0009-9     Document Type: Article

References (44)

1. C. Bjorbaek, B.B. Kahn, Leptin signaling in the central nervous system and the periphery. Recent Prog. Horm. Res. 59, 305-331 (2004)
2. A. Oswal, G. Yeo, Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity (Silver Spring) 18, 221-229 (2010)
3. K.G. Murphy, S.R. Bloom, Gut hormones and the regulation of energy homeostasis. Nature 444, 854-859 (2006)
4. H. Ariyasu, K. Takaya, T. Tagami et al., Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 86, 4753-4758 (2001)
5. T.R. Castaneda, J. Tong, R. Datta, M. Culler, M.H. Tschop, Ghrelin in the regulation of body weight and metabolism. Front. Neuroendocrinol. 31, 44-60 (2010)
6. P.J. English, M.A. Ghatei, I.A. Malik, S.R. Bloom, J.P. Wilding, Food fails to suppress ghrelin levels in obese humans. J. Clin. Endocrinol. Metab. 87, 2984-2987 (2002)
7. B. Otto, U. Cuntz, E. Fruehauf, R. Wawarta et al., Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 145, 669-673 (2001)
8. A.A. van der Klaauw, J.M. Keogh, E. Henning, A. Blackwood, A.M. Haqq, J.Q. Purnell, I.S. Farooqi, Postprandial total ghrelin suppression is modulated by melanocortin signaling in humans. J. Clin. Endocrinol. Metab. 98, E288-E292 (2013)
9. A.M. Haqq, I.S. Farooqi, S. O'Rahilly et al., Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 88, 174-178 (2003)
10. A.P. Goldstone, M. Patterson, N. Kalingag et al., Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J. Clin. Endocrinol. Metab. 90, 2681-2690 (2005)
11. E. Ekblad, F. Sundler, Distribution of pancreatic polypeptide and peptide YY. Peptides 23, 251-261 (2002)
12. R.L. Batterham, H. Heffron, S. Kapoor et al., Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 4, 223-233 (2006)
13. T.E. Adrian, G.L. Ferri, A.J. Bacarese-Hamilton, H.S. Fuessl, J.M. Polak, S.R. Bloom, Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89, 1070-1077 (1985)
14. A.A. van der Klaauw, J.M. Keogh, E. Henning, V.M. Trowse, W.S. Dhillo, M.A. Ghatei, I.S. Farooqi, High protein intake stimulates postprandial GLP1 and PYY release. Obesity (Silver Spring) (2012). doi:10.1002/oby.20154
15. R.A. Pittner, C.X. Moore, S.P. Bhavsar et al., Effects of PYY[3-36] in rodent models of diabetes and obesity. Int. J. Obes. Relat. Metab. Disord. 28, 963-971 (2004)
16. K. Zwirska-Korczala, S.J. Konturek, M. Sodowski et al., Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J. Physiol. Pharmacol. 58(Suppl 1), 13-35 (2007)
17. M.D. Turton, D. O'Shea, I. Gunn, S.A. Beak et al., A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69-72 (1996)
18. R.S. Ahima, S.Y. Osei, Leptin signaling. Physiol. Behav. 81, 223-241 (2004)
19. K.D. Niswender, M.W. Schwartz, Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front. Neuroendocrinol. 24, 1-10 (2003)
20. M.W. Schwartz, S.C. Woods, D. Porte Jr, R.J. Seeley, D.G. Baskin, Central nervous system control of food intake. Nature 404, 661-671 (2000)
21. A.J. van der Lely, M. Tschop, M.L. Heiman, E. Ghigo, Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25, 426-457 (2004)
22. C.T. Montague, I.S. Farooqi, J.P. Whitehead et al., Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903-908 (1997)
23. I.S. Farooqi, S. O'Rahilly, Monogenic human obesity syndromes. Recent Prog. Horm. Res. 59, 409-424 (2004)
24. S. Saeed, T.A. Butt, M. Anwer, M. Arslan, P. Froguel, High prevalence of leptin and melanocortin-4 receptor gene mutations in children with severe obesity from Pakistani consanguineous families. Mol. Genet. Metab. 106, 121-126 (2012)
25. A.I. Blakemore, P. Froguel, Investigation of Mendelian forms of obesity holds out the prospect of personalized medicine. Ann. N. Y. Acad. Sci. 1214, 180-189 (2010)
26. I.S. Farooqi, J.M. Keogh, S. Kamath et al., Partial leptin deficiency and human adiposity. Nature 414, 34-35 (2001)
27. A.M. Wren, L.J. Seal, M.A. Cohen et al., Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86, 5992-5995 (2001)
28. M. Tschop, C. Weyer, P.A. Tataranni, V. Devanarayan, E. Ravussin, M.L. Heiman, Circulating ghrelin levels are decreased in human obesity. Diabetes 50, 707-709 (2001)
29. Y. Sun, S. Ahmed, R.G. Smith, Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell. Biol. 23, 7973-7981 (2003)
30. H. Kirchner, K.M. Heppner, J. Holland, D. Kabra, M.H. Tschöp, P.T. Pfluger, Ablation of ghrelin O-acyltransferase does not improve glucose intolerance or body adiposity in mice on a leptin-deficient ob/ob background. PLoS One 8, e61822 (2013)
31. B.O. Yildiz, M.A. Suchard, M.L. Wong, S.M. McCann, J. Licinio, Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc. Natl. Acad. Sci. USA. 101, 10434-10439 (2004)
32. C. Bizzarri, A.E. Rigamonti, A. Luce et al., Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children. Eur. J. Endocrinol. 162, 499-505 (2010)
33. A.P. Goldstone, E.L. Thomas, A.E. Brynes et al., Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J. Clin. Endocrinol. Metab. 86, 4330-4338 (2001)
34. L. Purtell, L. Sze, G. Loughnan et al., In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels. Neuropeptides 4, 301-307 (2011)
35. A. De Silva, S.R. Bloom, Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut Liver 6, 10-20 (2012)
36. J.L. Chan, V. Stoyneva, T. Kelesidis, P. Raciti, C.S. Mantzoros, Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin. Diabetologia 49, 169-173 (2006)
37. M. Korbonits, P.J. Trainer, J.A. Little et al., Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity. Clin. Endocrinol. (Oxf.) 46, 751-757 (1997)
38. M. Romon, P. Lebel, J.C. Fruchart, J. Dallongeville, Postprandial leptin response to carbohydrate and fat meals in obese women. J. Am. Coll. Nutr. 22, 247-251 (2003)
39. J. Dallongeville, B. Hecquet, P. Lebel et al., Short term response of circulating leptin to feeding and fasting in man: influence of circadian cycle. Int. J. Obes. Relat. Metab. Disord. 22, 728-733 (1998)
40. I.S. Farooqi, G. Matarese, G.M. Lord et al., Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110, 1093-1103 (2002)
41. J. Levi, S.L. Gray, M. Speck et al., Acute disruption of leptin signaling in vivo leads to increased insulin levels and insulin resistance. Endocrinology 152, 3385-3395 (2011)
42. P.R. Flatt, C.J. Bailey, A.M. Cameron, B.J. Gould, Age effects on glycosylated blood proteins in lean and obese hyperglycaemic (ob/ob) mice. Diabetes Res. 3, 241-243 (1986)
43. J. Seufert, T.J. Kieffer, J.F. Habener, Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc. Natl. Acad. Sci. USA. 96, 674-679 (1999)
44. Y. Sun, M. Asnicar, P.K. Saha, L. Chan, R.G. Smith, Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 3, 379-386 (2006)